Exhibit (c)(vi) – CONFIDENTIAL PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION [****] indicates information has been omitted on the basis of a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. This information has been filed separately with the Securities and Exchange Commission. Presentation to the Board of Directors Project Picasso Goldman Sachs & Co. LLC April 24, 2024 Goldman Sachs does not provide accounting, tax, or legal advice. Notwithstanding anything in this document to the contrary, and except as required to enable compliance with applicable securities law, you (and each of your employees, representatives, and other agents) may disclose to any and all persons the US federal income and state tax treatment and tax structure of the transaction and all materials of any kind (including tax opinions and other tax analyses) that are provided to you relating to such tax treatment and tax structure, without Goldman Sachs imposing any limitation of any kind.

CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION Disclaimer These materials have been prepared and are provided by Goldman Sachs on a confidential basis solely for the information and assistance of the Board of Directors (the “Board ) and senior management of Picasso (the Company ) in connection with their consideration of the matters referred to herein. These materials and Goldman Sachs’ presentation relating to these materials (the “Confidential Information”) may not be disclosed to any third party or circulated or referred to publicly or used for or relied upon for any other purpose without the prior written consent of Goldman Sachs. The Confidential Information was not prepared with a view to public disclosure or to conform to any disclosure standards under any state, federal or international securities laws or other laws, rules or regulations, and Goldman Sachs does not take any responsibility for the use of the Confidential Information by persons other than those set forth above. Notwithstanding anything in this Confidential Information to the contrary, the Company may disclose to any person the US federal income and state income tax treatment and tax structure of any transaction described herein and all materials of any kind (including tax opinions and other tax analyses) that are provided to the Company relating to such tax treatment and tax structure, without Goldman Sachs imposing any limitation of any kind. The Confidential Information has been prepared by the Investment Banking Division of Goldman Sachs and is not a product of its research department. Goldman Sachs and its affiliates are engaged in advisory, underwriting and financing, principal investing, sales and trading, research, investment management and other financial and non-financial activities and services for various persons and entities. Goldman Sachs and its affiliates and employees, and funds or other entities they manage or in which they invest or have other economic interests or with which they co-invest, may at any time purchase, sell, hold or vote long or short positions and investments in securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments of the Company, any other party to any transaction and any of their respective affiliates or any currency or commodity that may be involved in any transaction. Goldman Sachs’ investment banking division maintains regular, ordinary course client service dialogues with clients and potential clients to review events, opportunities, and conditions in particular sectors and industries and, in that connection, Goldman Sachs may make reference to the Company, but Goldman Sachs will not disclose any confidential information received from the Company. The Confidential Information has been prepared based on historical financial information, forecasts and other information obtained by Goldman Sachs from publicly available sources, the management of the Company or other sources (approved for our use by the Company in the case of information from management and non-public information). In preparing the Confidential Information, Goldman Sachs has relied upon and assumed, without assuming any responsibility for independent verification, the accuracy and completeness of all of the financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by us, and Goldman Sachs does not assume any liability for any such information. Goldman Sachs does not provide accounting, tax, legal or regulatory advice. Goldman Sachs has not made an independent evaluation or appraisal of the assets and liabilities (including any contingent, derivative or other off-balance sheet assets and liabilities) of the Company or any other party to any transaction or any of their respective affiliates and has no obligation to evaluate the solvency of the Company or any other party to any transaction under any state or federal laws relating to bankruptcy, insolvency or similar matters. The analyses contained in the Confidential Information do not purport to be appraisals nor do they necessarily reflect the prices at which businesses or securities actually may be sold or purchased. Goldman Sachs’ role in any due diligence review is limited solely to performing such a review as it shall deem necessary to support its own advice and analysis and shall not be on behalf of the Company. Analyses based upon forecasts of future results are not necessarily indicative of actual future results, which may be significantly more or less favorable than suggested by these analyses, and Goldman Sachs does not assume responsibility if future results are materially different from those forecast. The Confidential Information does not address the underlying business decision of the Company to engage in any transaction, or the relative merits of any transaction or strategic alternative referred to herein as compared to any other transaction or alternative that may be available to the Company. The Confidential Information is necessarily based on economic, monetary, market and other conditions as in effect on, and the information made available to Goldman Sachs as of, the date of such Confidential Information and Goldman Sachs assumes no responsibility for updating or revising the Confidential Information based on circumstances, developments or events occurring after such date. The Confidential Information does not constitute any opinion, nor does the Confidential Information constitute a recommendation to the Board, any security holder of the Company or any other person as to how to vote or act with respect to any transaction or any other matter. The Confidential Information, including this disclaimer, is subject to, and governed by, any written agreement between the Company, the Board and/or any committee thereof, on the one hand, and Goldman Sachs, on the other hand. The Confidential Information does not address, nor does Goldman Sachs express any view as to, the potential effects of volatility in the credit, financial and stock markets on the Company, any other party to any transaction or any transaction. 2

CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION Table of Contents I. Process Update II. Valuation Perspectives Appendix A: Supplementary Materials 3

CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION I. Process Update

CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION Summary of Party Engagement Sponsors (9) Strategics (5) [****] [****][****] [****][****] Initial Engagement (14) [****] [****] [****] [****] [****] [****] [****][****] [****] [****] [****] Executed NDA, Management Presentations and/or Deep Dive Meetings (8) [****] [****][****] [****] Conducted extensive Non-Binding financial diligence as well as follow up sessions on [****] Written Proposals Other product development, tech Received stack and R&D spend Process Update 5

CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION Summary of Potential Bidders Feedback to Date Diligence Follow Up MP Sessions Q&A Latest Developments ◼ Enthusiastic about the company and management and would like to get a transaction done by earnings ◼ While they have received most of the information they need to this stage, they have requested additional time with ✓✓✓ management to walk through a product demo ◼ Current perspective on value based on assessment of market, retention, and product / growth initiatives ◼ Indicated a control transaction will be challenging and they would be willing to participate with another lead subject [****] ✓✓ to valuation with flexibility to deploy capital from several pockets ◼ Complimentary of management and the process having spent time engaging through a management presentation, several diligence sessions, and multiple touch points with GS team [****] ✓✓✓ ◼ Through the process they validated their initial assumptions, but were not able to get to an above market deal given conservatism around AI and international and a conservative M&A case ◼ Indicated this is a company with strong market leadership, strong organic and inorganic growth with tailwinds from AI [****] ✓✓ ◼ Commented that it will be tough to provide a notable premium to market, especially when factoring in the TRA; however, they would be interested in opportunities to provide liquidity through creative structures ◼ Indicated they have admiration for the company, but were having a hard time getting to a premium above market [****]✓✓ ✓ ◼ Expressed concerns over underwriting the combination of forward growth + margin but indicated they would be interested in providing liquidity through a structured transaction ◼ Expressed uncertainty on reaching 3x MOIC within next ~3-4 years given combination of organic investment ✓✓✓ [****] required coupled with delevering likely needed to go public again in that time frame ◼ More positive on the end market than other times where they have discussed the sector historically; however, they do not have bandwidth to take on given [****] integration in another complicated market (healthcare) ✓ [****] ◼ However, they believe this is a company that aligns with senior leadership aspiration and would like to stay close over the longer term (e.g., if there would be another opportunity to consider in 4-5 years) ◼ Conducted extensive financial diligence as well as follow up sessions on product development, tech stack and [****] R&D spend ✓✓✓ ◼ Continue to address diligence follow-up questions pertaining to financial profile [****] [****] [****] [****] [****] [****] Initial Pass Process Update 6 Strategics Tier 1 Sponsor

CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION Key Themes from Potential Bidder Feedback ◼ Respect for Picasso’s market leadership and quality of the business built to date ◼ Recent trends in net retention (potentially from ESSR funding roll off) could make longer term sustainable growth more challenging ◼ If funding headwinds are present, this could make the second half of the year more challenging ◼ Sponsors and strategics conveyed various challenges to submitting a proposal exceeding market prices for several reasons: — Combination of underwriting notable margin expansion coupled with plans to continue growing 10%+ through hold period — In particular, there was a view that the business requires a strong second half to the year and potential bidders models are highly sensitive to the net retention and organic growth required to meet 2024 budget and longer-term plan — Certain products including Schoology, SchoolMessenger, and Naviance are facing headwinds which puts pressure on the remaining cloud solutions — Historical growth from LMS is slowing and Picasso saw the benefits of several larger than normal contracts in the previous year — Conservatism in underwriting the full AI and International business plan – potential bidders often haircut these aspects in their plan given the early stages in both — Ability to underwrite full M&A plan available to Picasso as a private company — Most exit opportunities (e.g., sale to another sponsor) will prove challenging given anticipated scale of the business, especially in the current environment — Higher cost of capital at current rates makes returns more difficult and any M&A case more expensive — Limited IPO market over the past 2 years calls into question viability of clean exit — Capacity to take on control transaction given equity check likely required – some investors offered to think through structured solutions that would provide investment for funding M&A or potential secondary liquidity, but not a control transaction Note: Bold indicates Bain feedback. Process Update 7

CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION Summary of Bain Capital Proposal Date◼ April 24, 2024 ◼ $22.17 per share ($5.97B enterprise value) Headline Offer ◼ 25% premium to prior day’s closing share price Price ◼ 24x 2024E Unlevered Free Cash Flow of $248 Million ◼ Assumes $706M of net debt on Picasso’s balance sheet at close ◼ Assumes $500M liability associated with tax receivable agreement Offer Price Consideration ◼ Conversion of incentive units that vest at the transaction price into deferred cash awards to be paid out at the transaction price on the existing time-based vesting schedule ◼ Transaction will be funded through combination of equity funds from Bain Capital, third party equity co-investors, and third-party debt financing ◼ Request consent to include the following financing sources: Ares, Golub, Blackstone Credit, Financing HPS, Owl Rock, Sixth Street, Barclays, RBC, UBS, Jefferies and CalPERS. ◼ Require rollover from existing shareholders subject to Bain controlling a majority of the Pro Forma equity ◼ Completing diligence and signing definitive documentation by May 7, 2024 Timing ◼ Require any transaction in which the Sponsors [Vista and Onex] roll or in which there is a payment made under the Tax Receivable Agreement to be conditioned upon the approval of a fully-empowered special committee of the board comprised exclusively of directors Other independent from the Sponsors and approval of a majority of stockholders unaffiliated with the Sponsors Source: Bain Capital non-binding proposal dated April 24, 2024 . Process Update 8

CONFIDENTIAL – PRELIMINARY DRAFT II. Valuation Perspectives

CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION Picasso Stock Price History Since IPO $40.0 17-Apr-2024 Short-seller Spruce Point Management releases critical report Share Price Performance Since $30.0 Announcement: (11)% 52-Week High $ 25.16 $ 21.75 6-Month VWAP (2.9)% 3-Month VWAP $ 21.26 $ 21.14 1-Year VWAP $ 20.53 VWAP Since IPO $20.0 2-Year VWAP $ 19.90 Current $17.48 $ 16.41 52-Week Low $10.0 Jul-21 Jan-22 Jun-22 Nov-22 May-23 Oct-23 Apr-24 Source: FactSet; market data as of 22-Apr-2024 Note: Reflects trading performance from 28-Jul-2021 to 22-Apr-2024. Valuation Perspectives 10 Share Price (USD)

CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION Picasso Illustrative Analysis at Various Prices ($ in millions, except per share data) Current Final Bain Bid Illustrative Enterprise Value $ 4,463 $ 5,865 $ 5,951 $ 5,972 (-) Net Debt as of 30-Sep-2024 (706) (706) (706) (706) Implied Equity Value (excl. TRA) $ 3,757 $ 5,158 $ 5,244 $ 5,266 Fully Diluted Shares Outstanding as of 30-Jun-2024 214.94 214.94 214.94 214.94 Implied Share Price (excl. TRA) $ 17.48 $ 24.00 $ 24.40 $ 24.50 (-) TRA Guided Value (500) (500) (500) (500) Implied Equity Value (incl. TRA) $ 3,257 $ 4,658 $ 4,744 $ 4,766 Based on 9/30 balance sheet and Implied Share Price (incl. TRA) $ 15.15 $ 21.67 $ 22.07 $ 22.17 $500mm TRA change of control % Premium to Share Price Incl. TRA Current value, per Picasso Management to Current $ 17.48 (13)% 24 % 26 % 27 % to 52 Week High 25.16 (40) (14) (12) (12) to 52 Week Low 16.41 (8) 32 35 35 to 1 Month VWAP 19.64 (23) 10 12 13 to 3 Month VWAP 21.26 (29) 2 4 4 to 6 month VWAP 21.75 (30) (0) 1 2 to 1 Year VWAP 21.14 (28) 3 4 5 to 2 Year VWAP 19.90 (24) 9 11 11 Implied Equity Value $ 3,257 $ 4,658 $ 4,744 $ 4,766 % Premium to Share Price Exl. TRA Current to Current $ 17.48 0 % 37 % 40 % 40 % to 52 Week High 25.16 (31) (5) (3) (3) to 52 Week Low 16.41 7 46 49 49 to 1 Month VWAP 19.64 (11) 22 24 25 to 3 Month VWAP 21.26 (18) 13 15 15 to 6 month VWAP 21.75 (20) 10 12 13 to 1 Year VWAP 21.14 (17) 14 15 16 to 2 Year VWAP 19.90 (12) 21 23 23 Implied Equity Value $ 3,757 $ 5,158 $ 5,244 $ 5,266 Source: Picasso Management Plan; Company filings; market data as of 22-Apr-2024 Valuation Perspectives 11

CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION Picasso Illustrative Analysis at Various Prices (Cont’d) ($ in millions) Current Final Bain Bid Illustrative Enterprise Value $ 4,463 $ 5,865 $ 5,951 $ 5,972 Other Vertical EV / EBITDA (Management ) Metric Instructure Tyler Software CY2024E $ 277 16.1 x 21.2 x 21.5 x 21.6 x 14.0 x 32.8 x 28.4 x CY2025E 327 13.7 x 17.9 x 18.2 x 18.3 x 12.6 x 29.1 x 26.4 x Other Vertical EV / uFCF (Management ) Metric Instructure Tyler Software 1 CY2024E $ 248 18.0 x 23.6 x 24.0 x 24.1 x 16.0 x 44.2 x 34.4 x CY2025E 313 14.3 x 18.7 x 19.0 x 19.1 x 15.1 x 38.2 x 29.4 x Other Vertical EV / EBITDA (Street) Metric Instructure Tyler Software CY2024E $ 270 16.6 x 21.7 x 22.1 x 22.1 x 14.0 x 32.8 x 28.4 x CY2025E 307 14.5 x 19.1 x 19.4 x 19.5 x 12.6 x 29.1 x 26.4 x Other Vertical EV / uFCF (Street) Metric Instructure Tyler Software CY2024E $ 225 19.8 x 26.0 x 26.4 x 26.5 x 16.0 x 44.2 x 34.4 x CY2025E 278 16.1 x 21.1 x 21.4 x 21.5 x 15.1 x 38.2 x 29.4 x Source: Picasso Management Plan; Company filings; market data as of 22-Apr-2024 1 2024E uFCF normalized to exclude the $42mm of acquisition cash outflows. Valuation Perspectives 12

CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION Picasso Illustrative Standalone Valuation Summary Methodology Illustrative Share Price Commentary ◼ 9.0% - 10.5% Discount Rate Discounted Cash◼ 2.0% - 4.0% Perpetuity Growth Rate $ 18.00 $ 31.60 ◼ 10.75 Year DCF Flow ◼ Based on Picasso Management tax model ◼ Picasso Management Plan: $327 - $439mm (2025E – 2027E EBITDA) Present Value of ◼ High: 20.0x EV / NTM EBITDA Future Share Price $ 17.80 $ 27.40 ◼ Low: 16.0x EV / NTM EBITDA (EBITDA) ◼ Cost of Equity: 11.0% ◼ Picasso Management Plan: $313 - $428mm (2025E – 2027E UFCF) Present Value of ◼ High: 23.5x EV / NTM UFCF Future Share Price $ 21.60 $ 31.60 ◼ Low: 19.5x EV / NTM UFCF (uFCF) ◼ Cost of Equity: 11.0% ◼ Picasso share price of $17.48 (as of 22-Apr-2024) Precedent Premia th ◼ High: 75 Percentile of 51.9% $ 21.10 $ 26.60 th (2019 to Present) ◼ Low: 25 Percentile of 20.9% ◼ Picasso Management Plan: NTM EBITDA of $289mm Precedent Transactions ◼ High: 29.3x EV/NTM EBITDA $ 12.60 $ 35.10 (2019 to Present) ◼ Low: 12.6x EV/NTM EBITDA ◼ 52 Week Intra High: $25.16 (06-Feb-2024) Historical Trading $ 16.41 $ 25.16 ◼ 52 Week Intra Low: $16.41 (05-May-2023) ◼ High PV of Price Target: $27.00 – BofA: 26-Feb-2024 $ 22.50 $ 27.00 Analyst Target Price ◼ Low PV of Price Target: $22.50 – UBS: 26-Feb-2024 Median: $25.00 Current Price: $ 17.48 Bain Bid excl. TRA $[24.50] Source: Picasso Management Plan; Market data as of 22-Apr-2024 Bain Bid incl. TRA $22.17 Note: Illustrative share price includes the impact of TRA at ~$418M Book Value as of most recent public filings. Picasso guided potential bidders to ~$500M based on assumed $30 share price. Valuation Perspectives 13 For Reference

CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION Appendix A: Supplementary Materials

CONFIDENTIAL – PRELIMINARY DRAFT SUBJECT TO MATERIAL REVISION Common Stock Comparison ($ in millions, except per share data) EV / Revenue EV / EBITDA EV / uFCF EV / uFCF Revenue Growth EBITDA Margin uFCF Margin % of 52-Week Fully Diluted Enterprise Closing Price Company Name High Equity Value Value CY2024 CY2025 CY2024 CY2025 CY2024 CY2025 LFQ '23 - '25 CY2024 CY2025 CY2024 CY2025 Picasso (Management) $ 17.48 70 % $ 3.8 $ 5.1 6.5 x 5.9 x 18.5 x 15.7 x 20.6 x 16.4 x 13 % 11 % 35 % 37 % 31 % 36 % Picasso (Street) $ 17.48 70 % $ 3.8 $ 5.1 6.5 x 5.9 x 19.0 x 16.7 x 22.7 x 18.4 x 13 % 12 % 34 % 35 % 29 % 32 % Vertical Software Peers Appfolio $ 214.79 86 % $ 8.0 $ 7.8 10.1 x 8.5 x 39.2 x 29.9 x 52.2 x 41.6 x 39 % 18 % 26 % 28 % 19 % 20 % AspenTech 197.08 85 12.7 12.5 10.6 9.6 25.5 21.6 32.7 28.2 6 9 42 45 32 34 Autodesk 217.13 81 47.7 47.7 8.0 7.2 21.3 19.0 33.3 23.9 11 10 37 38 24 30 Descartes 91.47 99 8.0 7.7 12.3 11.1 27.9 24.8 35.6 29.4 17 10 44 45 35 38 Guidewire 109.79 91 9.2 8.8 8.6 7.6 NM 43.0 NM 44.1 4 11 14 18 14 17 1 Instructure 19.18 68 2.8 3.8 5.7 5.2 14.0 12.6 16.0 15.1 9 10 41 41 36 34 JAMF 19.15 86 2.7 2.8 4.6 4.0 28.9 18.1 29.5 16.6 16 14 16 22 15 24 Ncino 29.64 79 3.6 3.5 6.6 5.6 38.7 29.2 51.1 34.9 13 17 17 19 13 16 Paycor 70.58 86 11.0 10.4 9.1 7.6 NM 48.5 NM NM 29 20 13 16 11 12 SPS Commerce 168.64 80 6.4 6.1 9.9 8.6 33.3 28.1 42.5 36.9 19 14 30 31 23 23 Tyler Technologies 411.41 93 17.9 18.4 8.7 7.9 32.8 29.1 44.2 38.2 6 10 26 27 20 21 Veeva 199.06 85 32.8 28.8 10.7 9.4 27.0 23.3 24.4 23.2 12 14 40 40 44 40 Peer Mean 8.7 x 7.7 x 28.8 x 27.3 x 36.1 x 30.2 x 15 % 13 % 29 % 31 % 24 % 26 % Peer Median 8.9 x 7.8 x 28.4 x 26.4 x 34.4 x 29.4 x 13 % 12 % 28 % 30 % 21 % 24 % 1 Source: Picasso Management Plan; Company filings, FactSet median consensus estimates; market data as of 22-Apr-2024. Note: Maximum threshold for trading multiples set to 55.0x. Instructure EV PF for incremental debt and cash used for Parchment acquisition in Q1 2024. Supplementary Materials 15